(HealthDay)—For youth with type 1 diabetes, hemoglobin A1c (A1C) and waist-to-height ratio (WHtR) are modifiable risk factors that predict change in dyslipidemia, according to a study published online Jan. 26 in Diabetes ...
Feb 1, 2017
0
0
UT Southwestern Medical Center research supports an evidence-based medicine (EBM) approach that embraces individualized care to prevent overtreatment, specifically for patients with type 2 diabetes.
Jan 31, 2017
0
0
(HealthDay)—For patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study ...
Jan 23, 2017
0
0
(HealthDay)—A data-driven algorithm for personalized diabetes care can yield substantial improvements in hemoglobin A1c (HbA1c), according to a study published online Dec. 5 in Diabetes Care.
Dec 14, 2016
0
0
Defining pre-diabetes based on hemoglobin A1C, a common test that determines a long-term average blood sugar level, is the most accurate predictor of who will go on to develop long-term complications from diabetes, new Johns ...
Nov 17, 2016
0
25
(HealthDay)—Twenty-four weeks of empagliflozin + metformin correlates with a significantly greater reduction in hemoglobin A1c (HbA1c) compared with once-daily empagliflozin or twice-daily metformin, according to a study ...
Aug 16, 2016
0
3
(HealthDay)—A collaborative couples telephonic intervention is associated with significant improvement in hemoglobin A1c (A1C) levels, according to a study published online July in Diabetes Care.
Aug 8, 2016
0
0
(HealthDay)—Patient variables seem not to be associated with hemoglobin A1c (HbA1c) targets, according to a study published online June 22 in Diabetes Care.
Jul 11, 2016
0
9
Modern lifestyles have brought forth a series of astounding gadgets to improve the living quality and expanding lifespan. There are so many technologies created for better health care, but only so few can experience them. ...
Mar 22, 2016
0
109
(HealthDay)—For patients with type 2 diabetes on background glimepiride therapy, but not metformin, addition of ranolazine is associated with a significant reduction in hemoglobin A1c (HbA1c), according to research published ...
Jan 18, 2016
0
5
